Denali Advisors’s Merck MRK Stock Holding History

Denali Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,500	Closed	-$462K	–	338
2025 Q3	$462K	Buy	+5,500	New	+$453K	0.05%	236
2025 Q1	–	Sell	-4,835	Closed	-$481K	–	294
2024 Q4	$481K	Sell	4,835 -4,757	-50%	-$490K	0.05%	240
2024 Q3	$1.09M	Buy	+9,592	New	+$1.14M	0.12%	166

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Denali Advisors's MRK Position: Q4 2025 in Review

Denali Advisors sold out of Merck (MRK) in Q4 2025, closing a stake of 5,500 shares — an estimated $462K sold.

Denali Advisors first reported a position in MRK in Q3 2024 and held it in 3 quarters. The position peaked at $1.09M in Q3 2024. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Denali Advisors reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Denali Advisors sold 5,500 Merck shares in Q4 2025, an estimated $462K.
Denali Advisors first reported a position in Merck in Q3 2024 and held it in 3 quarters.
Denali Advisors's Merck position peaked at $1.09M in Q3 2024.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Denali Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.